Author:
Reim Pauline K.,Engelbrechtsen Line,Gybel-Brask Dorte,Schnurr Theresia M.,Kelstrup Louise,Høgdall Estrid V.,Hansen Torben
Abstract
AbstractThe fetal insulin hypothesis proposes that low birthweight and type 2 diabetes (T2D) in adulthood may be two phenotypes of the same genotype. In this study we aimed to explore this theory further by testing the effects of GWAS-identified genetic variants related to insulin release and sensitivity on fetal growth and blood flow from week 20 of gestation to birth and on placental weight at birth. We calculated genetic risk scores (GRS) of first phase insulin release (FPIR), fasting insulin (FI), combined insulin resistance and dyslipidaemia (IR + DLD) and insulin sensitivity (IS) in a study population of 665 genotyped newborns. Two-dimensional ultrasound measurements with estimation of fetal weight and blood flow were carried out at week 20, 25, and 32 of gestation in all 665 pregnancies. Birthweight and placental weight were registered at birth. Associations between the GRSs and fetal growth, blood flow and placental weight were investigated using linear mixed models. The FPIR GRS was directly associated with fetal growth from week 20 to birth, and both the FI GRS, IR + DLD GRS, and IS GRS were associated with placental weight at birth. Our findings indicate that insulin-related genetic variants might primarily affect fetal growth via the placenta.
Funder
Danish Cardiovascular Academy PhD Scholarship
Novo Nordisk Fonden
Publisher
Springer Science and Business Media LLC
Reference46 articles.
1. Barker, D. The intrauterine origins of cardiovascular and obstructive lung disease in adult life. The Marc Daniels Lecture 1990. J. R. Coll. Physicians Lond. 25, 129–133 (1991).
2. Barker, D. & Martyn, C. The maternal and fetal origins of cardiovascular disease. J. Epidemiol. Community Health 46, 8–11. https://doi.org/10.1136/jech.46.1.8 (1992).
3. Smith, C. J. et al. The impact of birth weight on cardiovascular disease risk in the Women’s Health Initiative. Nutr. Metab. Cardiovasc. Dis. 26, 239–245. https://doi.org/10.1016/j.numecd.2015.10.015 (2016).
4. Hughes, A. E., Hattersley, A. T., Flanagan, S. E. & Freathy, R. M. Two decades since the fetal insulin hypothesis: What have we learned from genetics?. Diabetologia 64, 717–726. https://doi.org/10.1007/s00125-021-05386-7 (2021).
5. Martin-Gronert, M. S. & Ozanne, S. E. Mechanisms underlying the developmental origins of disease. Rev. Endocr. Metab. Disord. 13, 85–92. https://doi.org/10.1007/s11154-012-9210-z (2012).